Liraglutide as an Additional Treatment to Insulin in Patients with Type 1 Diabetes Mellitus-A 52-Week Randomized Double-Blinded Placebo-Controlled Clinical Trial

被引：2
|
作者：
Dandona, Paresh
Ghanim, Husam
Kuhadiya, Nitesh D.
Shah, Tanvi
Hejna, Jeanne M.
Makdissi, Antoine
Batra, Manav
Chaudhuri, Ajay
机构：
来源：
DIABETES | 2018年 / 67卷
关键词：
D O I：
10.2337/db18-3-LB
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [31] A Randomized, Double-Blinded, Placebo-Controlled Multicenter Trial of Etanercept in the Treatment of Alcoholic Hepatitis
    Boetticher, Nicholas C.
    Peine, Craig J.
    Kwo, Paul
    Abrams, Gary A.
    Pateo, Tushar
    Aqel, Bashar
    Boardman, Lisa
    Gores, Gregory J.
    Harmsen, William S.
    McClain, Craig J.
    Kamath, Patrick S.
    Shah, Vijay H.
    GASTROENTEROLOGY, 2008, 135 (06) : 1953 - 1960
  • [32] Hookworm Treatment for Relapsing Multiple Sclerosis A Randomized Double-Blinded Placebo-Controlled Trial
    Tanasescu, Radu
    Tench, Christopher R.
    Constantinescu, Cris S.
    Telford, Gary
    Singh, Sonika
    Frakich, Nanci
    Onion, David
    Auer, Dorothee P.
    Gran, Bruno
    Evangelou, Nikos
    Falah, Yasser
    Ranshaw, Colin
    Cantacessi, Cinzia
    Jenkins, Timothy P.
    Pritchard, David I.
    JAMA NEUROLOGY, 2020, 77 (09) : 1089 - 1098
  • [33] EFFICACY OF GABAPENTIN IN THE TREATMENT OF ALCOHOL DEPENDENCE: A DOUBLE-BLINDED, RANDOMIZED, PLACEBO-CONTROLLED TRIAL
    Kalayasiri, R.
    Chompookham, P.
    Rukngan, W.
    Nilaban, S.
    Suwanmajo, S.
    Yoosom, P.
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2018, 42 : 13A - 13A
  • [34] Beneficial Effects of a Freeze-Dried Kale Bar on Type 2 Diabetes Patients: A Randomized, Double-Blinded, Placebo-Controlled Clinical Trial
    Jeppesen, Per Bendix
    Dorner, Amanda
    Yue, Yuan
    Poulsen, Nikolaj
    Andersen, Sofie Korsgaard
    Aalykke, Fie Breenfeldt
    Lambert, Max Norman Tandrup
    NUTRIENTS, 2024, 16 (21)
  • [35] The effect of liraglutide on cardiac autonomic function in type 2 diabetes: A prespecified secondary analysis from the LIRAFLAME randomized, double-blinded, placebo-controlled trial
    Sivalingam, Suvanjaa
    Hein Zobel, Emilie
    Hansen, Christian S.
    Ripa, Rasmus S.
    von Scholten, Bernt J.
    Rotbain Curovic, Viktor
    Kjaer, Andreas
    Jensen, Jacob K.
    Hansen, Tine W.
    Rossing, Peter
    DIABETES OBESITY & METABOLISM, 2022, 24 (08): : 1638 - 1642
  • [36] Dapagliflozin as Additional Treatment to Liraglutide and Insulin In Patients with Type 1 Diabetes: A Randomized Clinical Trial of 12 Weeks
    Kuhadiya, Nitesh D.
    Mehta, Aditya
    Ghanim, Husam
    Garg, Manisha
    Hejna, Jeanne
    Makdissi, Antoine
    Chaudhuri, Ajay
    Batra, Manav
    Dandona, Paresh
    DIABETES, 2016, 65 : A76 - A76
  • [37] Short-Acting Exenatide and Markers of Cardiovascular Disease in Type 1 Diabetes: A Randomized, Double-Blinded, Placebo-Controlled Trial
    Johansen, Nicklas J.
    Dejgaard, Thomas F.
    Lund, Asger
    Schluntz, Camilla
    Larsen, Emil List
    Poulsen, Henrik E.
    Gotze, Jens P.
    Moller, Holger
    Vilsboll, Tina
    Andersen, Henrik U.
    Knop, Filip K.
    DIABETES, 2020, 69
  • [38] Effects of low dose metformin in adolescents with type I diabetes mellitus: a randomized, double-blinded placebo-controlled study
    Nadeau, Kristen J.
    Chow, Kelsey
    Alam, Suhyla
    Lindquist, Kara
    Campbell, Sarah
    McFann, Kim
    Klingensmith, Georgeanna
    Walravens, Phillipe
    PEDIATRIC DIABETES, 2015, 16 (03) : 196 - 203
  • [39] LIRAGLUTIDE AS ADDITIONAL TREATMENT TO INSULIN IN OBESE PATIENTS WITH TYPE 1 DIABETES MELLITUS
    Kuhadiya, Nitesh D.
    Malik, Ritu
    Bellini, Natalie J.
    Patterson, Jane Lyons
    Traina, Andrea
    Makdissi, Antoine
    Dandona, Paresh
    ENDOCRINE PRACTICE, 2013, 19 (06) : 963 - 967
  • [40] Amantadine for COVID-19 treatment (ACT) study: a randomized, double-blinded, placebo-controlled clinical trial
    Weis, Nina
    Bollerup, Signe
    Sund, Jon Dissing
    Glamann, Jakob Borg
    Vinten, Caroline
    Jensen, Louise Riger
    Sejling, Christoffer
    Kledal, Thomas Nitschke
    Rosenkilde, Mette Marie
    CLINICAL MICROBIOLOGY AND INFECTION, 2023, 29 (10) : 1313 - 1319
12345